FIELD: medicine.
SUBSTANCE: according to the invention there is provided substituted indolequinoxalines of the formula 
(I), where R1 represents hydrogen or represents one or more similar or different substituent in positions from 7 to 10, selected of the group of halogen, low alkyl/alkoxy, hydroxy, triflouromethyl, trichloromethyl, triflouromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X represents CO or CH2, Y represents OH, NH2, NH-(CH2)n-R3, where R3 represents low alkyl, OH, NH2, NHR4 or NR5R6, where R4, R5 and R6 represent low alkyl or cycloalkyl independently and n represents integer from 2 to 4 provided that X represents CH2, Y represents OH or NH-(CH2)n-OH and its pharmaceutically acceptable salt. There is also provided pharmaceutical composition, containing these compounds, methods of compound producing, formula (I).
EFFECT: compounds are applied as medicine for treatment and prevention of autoimmune diseases.
15 cl, 1 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTAGONISTS OF PEPTIDE RECEPTOR FIXED WITH CALCITONIN GENE | 2003 |
|
RU2341526C2 |
| METHOD FOR PREPARING INDOLINONE DERIVATIVES | 2003 |
|
RU2299209C2 |
| HETEROCYCLIC DERIVATIVES OR THEIR SALTS WITH ACIDS OR BASES | 1990 |
|
RU2049784C1 |
| HETEROCYCLIC CONDENSED COMPOUNDS USEFUL AS ANTIDIURETIC AGENTS | 2005 |
|
RU2359969C2 |
| NOVEL DERIVATIVES OF BENZIMIDAZOLE AND THEIR USING AS MEDICAMENTS | 2002 |
|
RU2294326C2 |
| DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE-CONTAINING PHENOTHIAZINES AS INHIBITORS OF CHOLINESTERASES AND BLOCKERS OF SEROTONIN RECEPTORS 5-HT, METHODS OF OBTAINING THEIR CHLOROHYDRATES AND BASED ON THEM PHARMACEUTICAL PREPARATION | 2013 |
|
RU2530881C1 |
| NOVEL COMPOUNDS POSSESSING ANTI-INFLAMMATORY ACTIVITY AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 2001 |
|
RU2288225C2 |
| HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2764243C2 |
| OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2815636C1 |
| 5-AMINO-4,6-DISUBSTITUTED INDOLE AND 5-AMINO-4,6-DISUBSTITUTED INDOLINE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | 2008 |
|
RU2483060C2 |
